148 related articles for article (PubMed ID: 38089045)
1. Association between antihypertensive drugs and oral cancer: a drug target Mendelian randomization study.
Guo J; Liu R; Sheng F; Wu Q; Xu R; He H; Zhang G; Huang J; Zhang Z; Zhang R
Front Pharmacol; 2023; 14():1294297. PubMed ID: 38089045
[No Abstract] [Full Text] [Related]
2. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.
Huang W; Xiao J; Ji J; Chen L
Elife; 2021 Dec; 10():. PubMed ID: 34866576
[TBL] [Abstract][Full Text] [Related]
3. Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study.
Zhao C; Feng JL; Deng S; Wang XP; Fu YJ; Wang B; Li HS; Meng FC; Wang JS; Wang X
Front Cardiovasc Med; 2023; 10():1157467. PubMed ID: 37363097
[TBL] [Abstract][Full Text] [Related]
4. Association between blood pressure and different antihypertensive drugs with outcome after ischemic stroke: A Mendelian randomization study.
Liu H; Zhang X; Zhou Y; Nguyen TN; Zhang L; Xing P; Li Z; Shen H; Zhang Y; Hua W; Xu H; Zhu X; Chen L; Zuo Q; Zhao R; Li Q; Dai D; Zhang Y; Xu Y; Huang Q; Liu J; Yang P
Int J Stroke; 2023 Dec; 18(10):1247-1254. PubMed ID: 37337369
[TBL] [Abstract][Full Text] [Related]
5. Repurposing Antihypertensive and Statin Medications for Spinal Pain: A Mendelian Randomization Study.
Suri P; Elgaeva EE; Williams FMK; Freidin MB; Verzun DA; Tsepilov YA
Spine (Phila Pa 1976); 2023 Nov; 48(22):1568-1574. PubMed ID: 37539717
[TBL] [Abstract][Full Text] [Related]
6. Genetically predicted blood pressure, antihypertensive drugs and risk of heart failure: a Mendelian randomization study.
Lian J; Shi X; Jia X; Fan J; Wang Y; Zhao Y; Yang Y
J Hypertens; 2023 Jan; 41(1):44-50. PubMed ID: 36129112
[TBL] [Abstract][Full Text] [Related]
7. Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study.
Zhang K; Gao H; Chen M
Front Pharmacol; 2023; 14():1224737. PubMed ID: 38116083
[No Abstract] [Full Text] [Related]
8. Association between antihypertensive drugs and hepatocellular carcinoma: A trans-ancestry and drug-target Mendelian randomization study.
Wang Z; Lu J; Hu J
Liver Int; 2023 Jun; 43(6):1320-1331. PubMed ID: 37005366
[TBL] [Abstract][Full Text] [Related]
9. Association of antihypertensive drugs with fracture and bone mineral density: A comprehensive drug-target Mendelian randomization study.
Huang X; Zhang T; Guo P; Gong W; Zhu H; Zhao M; Yuan Z
Front Endocrinol (Lausanne); 2023; 14():1164387. PubMed ID: 37056679
[TBL] [Abstract][Full Text] [Related]
10. Associations between lipid-lowering drugs and pregnancy and perinatal outcomes: a Mendelian randomization study.
Wang R; Zhao J; Li L; Huo Y
J Hypertens; 2024 Apr; 42(4):727-734. PubMed ID: 38230624
[TBL] [Abstract][Full Text] [Related]
11. Can Lipid-Lowering Drugs Reduce the Risk of Cholelithiasis? A Mendelian Randomization Study.
Dong H; Chen R; Xu F; Cheng F
Clin Epidemiol; 2024; 16():131-141. PubMed ID: 38410417
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive drug targets and breast cancer risk: a two-sample Mendelian randomization study.
Zheng G; Chattopadhyay S; Sundquist J; Sundquist K; Ji J
Eur J Epidemiol; 2024 Feb; ():. PubMed ID: 38396187
[TBL] [Abstract][Full Text] [Related]
13. Impact of blood pressure and antihypertensive drug classes on intracranial aneurysm: a Mendelian randomization study.
Zeng Y; Guo R; Cao S; Yang H
J Stroke Cerebrovasc Dis; 2023 Nov; 32(11):107355. PubMed ID: 37716106
[TBL] [Abstract][Full Text] [Related]
14. Obesity and head and neck cancer risk: a mendelian randomization study.
Gui L; He X; Tang L; Yao J; Pi J
BMC Med Genomics; 2023 Aug; 16(1):200. PubMed ID: 37620971
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipids, alcohol intake frequency and risk of Osteoarthritis: a Mendelian randomization study.
Wen MT; Liang XZ; Luo D; Li JC; Yan BZ; Lu BW; Xu B; Li G
BMC Public Health; 2023 Jul; 23(1):1327. PubMed ID: 37434151
[TBL] [Abstract][Full Text] [Related]
16. The effects of blood pressure and antihypertensive drugs on heart failure: A Mendelian randomization study.
Li Y; Xiao W; Huang N; Zhuang Z; Zhang L; Wang W; Song Z; Zhao Y; Dong X; Xu M; Huang T
Nutr Metab Cardiovasc Dis; 2023 Jul; 33(7):1420-1428. PubMed ID: 37156668
[TBL] [Abstract][Full Text] [Related]
17. Using Mendelian randomization to explore the gateway hypothesis: possible causal effects of smoking initiation and alcohol consumption on substance use outcomes.
Reed ZE; Wootton RE; Munafò MR
Addiction; 2022 Mar; 117(3):741-750. PubMed ID: 34590374
[TBL] [Abstract][Full Text] [Related]
18. Genetic causal relationship between age at menarche and benign oesophageal neoplasia identified by a Mendelian randomization study.
Su Y; Hu Y; Xu Y; Yang M; Wu F; Peng Y
Front Endocrinol (Lausanne); 2023; 14():1113765. PubMed ID: 37025412
[TBL] [Abstract][Full Text] [Related]
19. Causal association between body mass index and autoimmune thyroiditis: evidence from Mendelian randomization.
Huo J; Xu Y; Yu J; Guo Y; Hu X; Ou D; Qu R; Zhao L
Eur J Med Res; 2023 Nov; 28(1):526. PubMed ID: 37974233
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.
Li Y; Sundquist K; Zhang N; Wang X; Sundquist J; Memon AA
EBioMedicine; 2023 Feb; 88():104432. PubMed ID: 36634566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]